The GALT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GALT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GALT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View GALT Detailed Price Forecast - CNN Money | View GALT Detailed Summary - Google Finance | ||
View GALT Detailed Summary - Yahoo! Finance | View GALT Stock Research & Analysis - Zacks.com |
View GALT Trends & Analysis - Trade-Ideas | View GALT Major Holders - Barrons | ||
View GALT Call Transcripts - NASDAQ | View GALT Breaking News & Analysis - Seeking Alpha | ||
View GALT Annual Report - CompanySpotlight.com | View GALT OTC Short Report - OTCShortReport.com | ||
View GALT Fundamentals - TradeKing | View GALT SEC Filings - Bar Chart | ||
View Historical Prices for GALT - The WSJ | View Performance/Total Return for GALT - Morningstar | ||
View the Analyst Estimates for GALT - MarketWatch | View the Earnings History for GALT - CNBC | ||
View the GALT Earnings - StockMarketWatch | View GALT Buy or Sell Recommendations - MacroAxis | ||
View the GALT Bullish Patterns - American Bulls | View GALT Short Pain Metrics - ShortPainBot.com |
View GALT Stock Mentions - StockTwits | View GALT Stock Mentions - PennyStockTweets | ||
View GALT Stock Mentions - Twitter | View GALT Investment Forum News - Investor Hub | ||
View GALT Stock Mentions - Yahoo! Message Board | View GALT Stock Mentions - Seeking Alpha |
View Insider Transactions for GALT - SECform4.com | View Insider Transactions for GALT - Insider Cow | ||
View GALT Major Holdings Summary - CNBC | View Insider Disclosure for GALT - OTC Markets | ||
View Insider Transactions for GALT - Yahoo! Finance | View Institutional Holdings for GALT - NASDAQ |
View GALT Stock Insight & Charts - FinViz.com | View GALT Investment Charts - StockCharts.com | ||
View GALT Stock Overview & Charts - BarChart | View GALT User Generated Charts - Trading View |
Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development
Posted on Tuesday March 12, 2024
NORCROSS, Ga., March 12, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced the appointment of Khurram Jamil, M.D. as Vice President, Clinical Development. Dr. Jamil brings to Galectin almost two decades of experience in clinical development across the biotechnology industry. “We are pleased to welcome Khurram to the Galectin team at such a meaningful time of our development program” said Pol F
Retail investors account for 55% of Galectin Therapeutics Inc.'s (NASDAQ:GALT) ownership, while insiders account for 21%
Posted on Wednesday February 21, 2024
Key Insights Galectin Therapeutics' significant retail investors ownership suggests that the key decisions are...
Galectin Therapeutics Inc (GALT) Reports Increased Net Loss in Q3 2023
Posted on Monday November 13, 2023
Company Faces Higher R&D Expenses Amid Progress in Clinical Programs
UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
Posted on Monday November 13, 2023
NORCROSS, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ended September 30, 2023. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the U.S. Securities and Exchange Commission and is available at www.sec.gov. Joel Lewis, Chief Executive Officer and President